NCT00951158 A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT00949624 CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00949559 Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00947739 Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT00935844 Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT00932126 This Is The First Study Using Escalating Doses Of PF-03758309, An Oral Compound, In Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT00915083 A Phase I Study to Assess the Safety, Pharmacokinetics, and Potential Effects of Amrubicin on the QT/QTc Interval in Cancer Patients With Advanced Solid Tumors. Status COMPLETED Phase PHASE1
NCT00908908 A Study to Determine the Metabolism and Elimination of Carbon-14 Labeled Eribulin Acetate (14C-Eribulin) in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00879684 Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00879554 A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00877474 Phase I, Multicenter, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM01183 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00874042 Dose Escalation Study of ARQ 197 in Combination With Gemcitabine in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00861419 To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib. Status COMPLETED Phase PHASE1
NCT00861328 Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin Status COMPLETED Phase PHASE1
NCT00858377 A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00842335 A Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00831896 Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematological Malignancies Status COMPLETED Phase PHASE1